In summary, the humanized recombinant anti-CEA M5A∆CH2-C5 antibody has the potential to be a valuable diagnostic tool for immunoPET imaging of colorectal cancer in the clinic. This evidence concerns the gene CEACAM5 and colorectal cancer.